Skip to content

Free cash flow at other companies

AbbVie logo
AbbVieABBV
$3.56B+155%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
$3.98M+110%
Estee Lauder Companies Inc. logo
Estee Lauder Companies Inc.EL
$310M+91.4%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$374K+122%
NuSkin Enterprises logo
NuSkin EnterprisesNUS
-$17.63M-33.6%
Kenvue logo
KenvueKVUE
$350M+40.6%

Other financials

Income statement

See full
Revenue$64.9M-6.7%
Gross profit$44.4M-8.5%
Operating income-$1.8M+85.0%
Net income-$6.6M+34.3%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$204.4M-45.2%
Total debt$125.9M+756%
Total equity$55.2M+19.9%
Total assets$473.2M-29.8%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$224.0K+398%

Valuation

See full
Market cap$89.75M-63.3%
Enterprise value$11.24M-97.3%
P/S0.3×-0.5×

Profitability

See full
Gross margin64.9%+8.3pp
Operating margin-3.6%-1.6pp
Net margin-2%-0.9pp
FCF margin9.6%

Returns & leverage

See full
Return on equity-12%-5.4pp
Debt / equity2.3×+2.0×
Current ratio1.8×-5.7×

Where this comes from

Calculated from The Beauty Health Company’s reported figures.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beauty Health Company's free cash flow?
The Beauty Health Company (SKIN) reported free cash flow of -$5.78M in Q1 2026.
How has The Beauty Health Company's free cash flow changed year-over-year?
The Beauty Health Company's free cash flow decreased by 295.8% year-over-year, from $2.95M to -$5.78M.
What is the long-term trend for The Beauty Health Company's free cash flow?
Over 2 years (2021 to 2025), The Beauty Health Company's free cash flow has grown at a -3.2% compound annual growth rate (CAGR), from -$39.71M to $37.18M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.